THURSDAY, Nov. 18, 2021 (HealthDay News) — Gene therapy shows promise in reducing, and even halting, potentially life-threatening bleeding events in people with hemophilia, researchers report. Hemophilia A is the most common inherited bleeding disorder, affecting one in 5,000 males worldwide. It’s caused by a missing coagulation factor called FVIII.Continue Reading

TUESDAY, Nov. 16, 2021 (HealthDay News) — Heart failure patients who fit a specific profile can benefit from injection of stem cells delivered directly into their heart muscle, a new study finds. Patients with mild or moderate heart failure who have high levels of inflammation responded well to the stemContinue Reading

THURSDAY, Nov. 4, 2021 (HealthDay News) — An experimental gene therapy to boost the effectiveness of the Parkinson’s drug levodopa yielded promising results in mice, researchers report. As the loss of dopamine-releasing neurons advances in late-stage Parkinson’s, levodopa is less able to ease movement problems caused by the disease, whichContinue Reading

THURSDAY, Oct. 21, 2021 (HealthDay News) — Nine of 10 patients with so-called “bubble boy” immune disease who received gene therapy about a decade ago are still disease-free, researchers report. The gene therapy was developed at the University of California, Los Angeles (UCLA), to treat the rare and deadly immuneContinue Reading

TUESDAY, Oct. 12, 2021 (HealthDay News) — After knee replacement surgery, many patients experience a level of pain that has them reaching for prescription opioid painkillers. Now new research suggests that using acupuncture during the operation may help reduce that pain without raising the risk of addiction. “The opioid epidemicContinue Reading

THURSDAY, Sept. 16, 2021 (HealthDay News) — Multiple sclerosis (MS) patients undergoing a treatment that depletes a type of immune cell that fuels MS attacks still have a strong response to mRNA COVID-19 vaccines, a new study finds. “The message from this study is clear — it is worthwhile forContinue Reading